“A Prospective Clinical Study for Safety and Efficacy of Intralesional Tuberculin Purified Protein Derivative in Treatment of Palmoplantar Verruca” (2022) Journal of Nobel Medical College, 11(1), pp. 12–16. doi:10.3126/jonmc.v11i1.45720.